These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 21117969
1. Impact of new Clinical Laboratory Standards Institute Streptococcus pneumoniae penicillin susceptibility testing breakpoints on reported resistance changes over time. Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. Microb Drug Resist; 2011 Mar; 17(1):47-52. PubMed ID: 21117969 [Abstract] [Full Text] [Related]
2. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Farrell DJ, Klugman KP, Pichichero M. Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873 [Abstract] [Full Text] [Related]
3. Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States. Andam CP, Worby CJ, Gierke R, McGee L, Pilishvili T, Hanage WP. Emerg Infect Dis; 2017 Jun; 23(6):1012-1015. PubMed ID: 28518018 [Abstract] [Full Text] [Related]
4. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Clin Infect Dis; 2009 Feb 01; 48(3):e23-33. PubMed ID: 19115971 [Abstract] [Full Text] [Related]
5. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Mera R, Miller LA, Fritsche TR, Jones RN. Microb Drug Resist; 2008 Jun 01; 14(2):101-7. PubMed ID: 18491947 [Abstract] [Full Text] [Related]
6. Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013). Imöhl M, Reinert RR, Tulkens PM, van der Linden M. Eur J Clin Microbiol Infect Dis; 2014 Nov 01; 33(11):2035-40. PubMed ID: 24930041 [Abstract] [Full Text] [Related]
7. Effect of new breakpoints proposed by Clinical and Laboratory Standards Institute in 2008 for evaluating penicillin resistance of Streptococcus pneumoniae in a Turkish University Hospital. Doğan O, Gülmez D, Hasçelik G. Microb Drug Resist; 2010 Mar 01; 16(1):39-41. PubMed ID: 19916790 [Abstract] [Full Text] [Related]
8. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae. Davies TA, Yee YC, Bush K, Sahm D, Evangelista A, Goldschmidt R. Microb Drug Resist; 2008 Sep 01; 14(3):187-96. PubMed ID: 18707553 [Abstract] [Full Text] [Related]
9. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH. Pediatr Infect Dis J; 2007 Jun 01; 26(6):461-7. PubMed ID: 17529859 [Abstract] [Full Text] [Related]
10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E, Albert MJ. Vaccine; 2012 Dec 31; 30 Suppl 6():G37-40. PubMed ID: 23228356 [Abstract] [Full Text] [Related]
11. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae--United States, 2006-2007. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2008 Dec 19; 57(50):1353-5. PubMed ID: 19092758 [Abstract] [Full Text] [Related]
12. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Shibl AM, Memish ZA, Al-Kattan KM. Vaccine; 2012 Dec 31; 30 Suppl 6():G32-6. PubMed ID: 23228355 [Abstract] [Full Text] [Related]
13. New penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effects on susceptibility categorisation in Germany (1992-2008). Imöhl M, Reinert RR, van der Linden M. Int J Antimicrob Agents; 2009 Sep 31; 34(3):271-3. PubMed ID: 19419844 [Abstract] [Full Text] [Related]
14. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ. Clin Microbiol Infect; 2009 Apr 31; 15 Suppl 3():4-6. PubMed ID: 19366362 [Abstract] [Full Text] [Related]
15. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CR, Gilio AE, Martinez MB. Vaccine; 2013 Dec 09; 31(51):6150-4. PubMed ID: 23747454 [Abstract] [Full Text] [Related]
16. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, Klugman KP. Antimicrob Agents Chemother; 2004 Sep 09; 48(9):3491-7. PubMed ID: 15328116 [Abstract] [Full Text] [Related]
17. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain. Fenoll A, Aguilar L, Giménez MJ, Vicioso MD, Robledo O, Granizo JJ, Coronel P. Int J Antimicrob Agents; 2012 Jul 09; 40(1):18-23. PubMed ID: 22578763 [Abstract] [Full Text] [Related]
18. Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005. Lee S, Lee K, Kang Y, Bae S. Microb Drug Resist; 2010 Jun 09; 16(2):135-42. PubMed ID: 20370508 [Abstract] [Full Text] [Related]
19. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae? Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D. J Antimicrob Chemother; 2008 Dec 09; 62(6):1430-3. PubMed ID: 18819966 [Abstract] [Full Text] [Related]
20. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era. Flamaing J, Verhaegen J, Vandeven J, Verbiest N, Peetermans WE. J Antimicrob Chemother; 2008 Jan 09; 61(1):143-9. PubMed ID: 17999974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]